Federico Longo

Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis

Sebastián Morán, Anna Martínez‐Cardús, Sergi Sayols et al. · The Lancet Oncology · 2016 · 510 citations

Medicine, Molecular Biology, Oncology +16

Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study

Michele Maio, Paolo A. Ascierto, L. V. Manzyuk et al. · Annals of Oncology · 2022 · 445 citations · Full text

Life Sciences, Oncology, Immunotherapy +13

Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry

Paula Jiménez Fonseca, Alberto Carmona‐Bayonas, Raquel Hernández et al. · British Journal of Cancer · 2017 · 103 citations · Full text

Medicine, Oncology, Chemotherapy +12

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors

Iván Márquez‐Rodas, Federico Longo, María E. Rodríguez-Ruiz et al. · Science Translational Medicine · 2020 · 84 citations

Life Sciences, Immunology, Oncology +16

SEOM clinical guideline on unknown primary cancer (2017)

Ferrán Losa, G. Soler, Antonio Casado et al. · Clinical & Translational Oncology · 2017 · 71 citations · Full text

Veterinary Medicine, Oncology, Pathology +17